109 related articles for article (PubMed ID: 2211056)
1. Physical and acoustical properties of perfluorooctylbromide, an ultrasound contrast agent.
André M; Nelson T; Mattrey R
Invest Radiol; 1990 Sep; 25(9):983-7. PubMed ID: 2211056
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of the echogenicity of flowing blood by the contrast agent perflubron.
André MP; Steinbach G; Mattrey RF
Invest Radiol; 1993 Jun; 28(6):502-6. PubMed ID: 8320067
[TBL] [Abstract][Full Text] [Related]
3. Perfluorooctylbromide nanoparticles for ultrasound imaging and drug delivery.
Li X; Sui Z; Li X; Xu W; Guo Q; Sun J; Jing F
Int J Nanomedicine; 2018; 13():3053-3067. PubMed ID: 29872293
[TBL] [Abstract][Full Text] [Related]
4. In vivo estimation of perfluorooctylbromide concentration in tissues.
Mattrey RF; Nemcek AA; Shelton R; André MP; Mitten RM; Peterson T
Invest Radiol; 1990 Aug; 25(8):915-21. PubMed ID: 2394575
[TBL] [Abstract][Full Text] [Related]
5. Computed tomographic enhancement of the liver, liver abscesses, spleen, and major vessels with perfluorooctylbromide emulsion. Influence of dosage and injection velocity in an animal model.
Adam G; Günther RW; Schiffer C; Görtz H; Prescher A; Scherer K
Invest Radiol; 1992 Sep; 27(9):698-705. PubMed ID: 1399453
[TBL] [Abstract][Full Text] [Related]
6. Effect of emulsion concentration on biodistribution of perflubron in tumor-bearing mice.
Long DM; Witt BL; Escobar JA; Long RA
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):907-10. PubMed ID: 1391531
[TBL] [Abstract][Full Text] [Related]
7. Towards a nanoscale mammographic contrast agent: development of a modular pre-clinical dual optical/x-ray agent.
Hill ML; Gorelikov I; Niroui F; Levitin RB; Mainprize JG; Yaffe MJ; Rowlands JA; Matsuura N
Phys Med Biol; 2013 Aug; 58(15):5215-35. PubMed ID: 23851978
[TBL] [Abstract][Full Text] [Related]
8. Perfluoroctylbromide: a liver/spleen-specific and tumor-imaging ultrasound contrast material.
Mattrey RF; Scheible FW; Gosink BB; Leopold GR; Long DM; Higgins CB
Radiology; 1982 Dec; 145(3):759-62. PubMed ID: 7146409
[TBL] [Abstract][Full Text] [Related]
9. Perfluoroctylbromide: a reticuloendothelial-specific and tumor-imaging agent for computed tomography.
Mattrey RF; Long DM; Multer F; Mitten R; Higgins CB
Radiology; 1982 Dec; 145(3):755-8. PubMed ID: 7146408
[TBL] [Abstract][Full Text] [Related]
10. Potential role of PFOB enhanced sonography of the kidney. II. Detection of partial infarction.
Coley BD; Mattrey RF; Roberts A; Keane S
Kidney Int; 1991 Apr; 39(4):740-5. PubMed ID: 2051732
[TBL] [Abstract][Full Text] [Related]
11. Use of fluorine-19 nuclear magnetic resonance spectroscopy and hydralazine for measuring dynamic changes in blood perfusion volume in tumors in mice.
Thomas C; Counsell C; Wood P; Adams GE
J Natl Cancer Inst; 1992 Feb; 84(3):174-80. PubMed ID: 1542128
[TBL] [Abstract][Full Text] [Related]
12. Micron-sized PFOB liquid core droplets stabilized with tailored-made perfluorinated surfactants as a new class of endovascular sono-sensitizers for focused ultrasound thermotherapy.
Desgranges S; Lorton O; Gui-Levy L; Guillemin P; Celicanin Z; Hyacinthe JN; Breguet R; Crowe LA; Becker CD; Soulié M; Taulier N; Contino-Pépin C; Salomir R
J Mater Chem B; 2019 Feb; 7(6):927-939. PubMed ID: 32255098
[TBL] [Abstract][Full Text] [Related]
13. Perfluoroctylbromide as a blood pool contrast agent for liver, spleen, and vascular imaging in computed tomography.
Mattrey RF; Long DM; Peck WW; Slutsky RA; Higgins CB
J Comput Assist Tomogr; 1984 Aug; 8(4):739-44. PubMed ID: 6736376
[TBL] [Abstract][Full Text] [Related]
14. Perfluorooctyl bromide traces self-assembled with polymeric nanovesicles for blood pool ultrasound imaging.
Li H; Wang P; Wang X; Yin T; Zhou G; Shuai X; Zheng R
Biomater Sci; 2016 Jun; 4(6):979-88. PubMed ID: 27121357
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic effects of intravenous lecithin-based perfluorocarbon emulsions in dogs.
Mattrey RF; Hilpert PL; Long CD; Long DM; Mitten RM; Peterson T
Crit Care Med; 1989 Jul; 17(7):652-6. PubMed ID: 2736927
[TBL] [Abstract][Full Text] [Related]
16. Perfluoroctylbromide. Acute hemodynamic effects, in pigs, of intravenous administration compared with the standard ionic contrast media.
Peck WW; Mattrey RF; Slutsky RA; Higgins CB
Invest Radiol; 1984; 19(2):129-32. PubMed ID: 6533103
[TBL] [Abstract][Full Text] [Related]
17. [Interaction of perfluoroctylbromide with liver microsomal monooxygenase].
Obraztsov VV; Grishanova AIu; Shekhtman DG; Sklifas AN; Makarov KN
Biokhimiia; 1993 Aug; 58(8):1234-9. PubMed ID: 8399771
[TBL] [Abstract][Full Text] [Related]
18. Characterization of perfluorooctylbromide-based nanoemulsion particles using atomistic molecular dynamics simulations.
Lee SJ; Olsen B; Schlesinger PH; Baker NA
J Phys Chem B; 2010 Aug; 114(31):10086-96. PubMed ID: 20684632
[TBL] [Abstract][Full Text] [Related]
19. In vitro comparison of dodecafluoropentane (DDFP), perfluorodecalin (PFD), and perfluoroctylbromide (PFOB) in the facilitation of oxygen exchange.
Johnson JL; Dolezal MC; Kerschen A; Matsunaga TO; Unger EC
Artif Cells Blood Substit Immobil Biotechnol; 2009; 37(4):156-62. PubMed ID: 19548131
[TBL] [Abstract][Full Text] [Related]
20. Effects of a perfluorocarbon emulsion on regional cerebral blood flow and metabolism after fluid resuscitation from hemorrhage in conscious rats.
Waschke KF; Riedel M; Albrecht DM; van Ackern K; Kuschinsky W
Anesth Analg; 1994 Nov; 79(5):874-82. PubMed ID: 7978403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
